Login
$ELOX
$12.75 -$0.40 (3.04%) Live

$ELOX SEC Filings

Filed On Filing
16 Nov 2026 8-K: Results of Operations and Financial Condition

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

13 Nov 2026 SCHEDULE 13G/A
21 Oct 2026 Form 4: Germano Geno J, Director

Granted 13,587 Stock Option (Right to Buy)

22 Oct 2026 424B3
21 Oct 2026 Form 3: Germano Geno J, Director

No securities owned

22 Oct 2026 8-K: Departure/Election of Directors or Officers; Compensation; Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

18 Sep 2026 EFFECT
11 Sep 2026 S-1
14 Aug 2026 SCHEDULE 13G
14 Aug 2026 SCHEDULE 13G
11 Aug 2026 8-K: Results of Operations and Financial Condition

Completed underwritten public offering with gross proceeds of $66.0 million and uplisting to the Nasdaq Capital Market, significantly strengthening the Company’s balance sheet

11 Aug 2026 10-Q
27 Jul 2026 SCHEDULE 13G
17 Jun 2026 SCHEDULE 13G
17 Jun 2026 Form 4: Domicilium Real Estate Fund Iii Lp, 10% owner

Acquired 600,000 shares (Other Transaction) · Acquired 600,000 Pre-funded Warrant (Other Transaction)

17 Jun 2026 Form 3: Domicilium Real Estate Fund Iii Lp, 10% owner

Holds 14,285 shares of common stock, $0.01 par value per share

17 Jun 2026 SCHEDULE 13G
16 Jun 2026 SCHEDULE 13G
16 Jun 2026 SCHEDULE 13G
15 Jun 2026 SCHEDULE 13G

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support